FORMULA GROWTH LTD - VERACYTE INC ownership

VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 189 filers reported holding VERACYTE INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
FORMULA GROWTH LTD ownership history of VERACYTE INC
ValueSharesWeighting
Q3 2023$602,910
-43.6%
27,000
-35.7%
0.21%
-39.6%
Q2 2023$1,069,740
+14.2%
42,0000.0%0.34%
+12.9%
Q1 2023$936,600
-6.0%
42,0000.0%0.30%
+7.1%
Q4 2022$996,660
+43.0%
42,0000.0%0.28%
+41.7%
Q3 2022$697,000
-16.6%
42,0000.0%0.20%
-14.2%
Q2 2022$836,000
-27.8%
42,0000.0%0.23%
+6.4%
Q1 2022$1,158,000
-45.9%
42,000
-19.2%
0.22%
-42.6%
Q4 2021$2,142,000
-11.3%
52,0000.0%0.38%
+9.8%
Q3 2021$2,415,000
+16.2%
52,0000.0%0.35%
+20.6%
Q2 2021$2,079,000
-25.6%
52,0000.0%0.29%
-28.6%
Q1 2021$2,795,000
+0.2%
52,000
-8.8%
0.40%
-13.7%
Q4 2020$2,790,000
+14.5%
57,000
-24.0%
0.47%
+2.2%
Q3 2020$2,437,000
+25.4%
75,0000.0%0.46%
+38.6%
Q2 2020$1,943,000
+6.6%
75,0000.0%0.33%
-5.7%
Q1 2020$1,823,000
-12.9%
75,0000.0%0.35%
+32.2%
Q4 2019$2,094,000
+9.1%
75,000
-6.2%
0.26%
-8.3%
Q3 2019$1,920,000
-15.8%
80,0000.0%0.29%
-11.7%
Q2 2019$2,281,000
+21.5%
80,000
+6.7%
0.33%
+23.0%
Q1 2019$1,877,000
+98.8%
75,0000.0%0.26%
+71.0%
Q4 2018$944,000
+31.8%
75,0000.0%0.16%
+89.0%
Q3 2018$716,000
+104.6%
75,000
+15.8%
0.08%
-2.4%
Q1 2016$350,000
-29.0%
64,785
-5.4%
0.08%
-27.0%
Q4 2015$493,00068,4860.12%
Other shareholders
VERACYTE INC shareholders Q3 2020
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 3,513,161$27,192,00010.11%
Stonepine Capital Management, LLC 970,500$7,512,0004.47%
Cannell Capital 1,079,587$8,356,0002.66%
First Light Asset Management, LLC 692,210$5,358,0002.36%
Broadfin Capital, LLC 1,788,266$13,841,0001.54%
Avoro Capital Advisors LLC 906,999$7,020,0001.42%
Eventide Asset Management 2,252,000$17,430,0001.13%
ACUTA CAPITAL PARTNERS, LLC 375,000$2,903,0001.08%
Grandeur Peak Global Advisors, LLC 534,752$4,139,0000.76%
WALL STREET ASSOCIATES 91,661$709,0000.47%
View complete list of VERACYTE INC shareholders